Monthly Archives: January 2011

Brazilian Attorney General of the Union restricts ANVISA’s role in pharmaceutical patent review

We are receiving reports from Brazil that the Brazilian Attorney General of the Union (AGU) has adopted a position restricting the role of the National Agency for Sanitary Surveillance (ANVISA) in the patenting process for pharmaceutical products and processes.  Due to a lack of clarity in the Industrial Property Law, ANVISA has used its prior consent role to reject patent applications on the basis of novelty and inventiveness which is officially the role of the Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

BIO Press Release: Former British Prime Minister Tony Blair to Present a Keynote Address at 2011 BIO International Convention

Former British Prime Minister Tony Blair to Present a Keynote Address at 2011 BIO International Convention   Convention to take place June 27-30, 2011 in Washington, DC   WASHINGTON, D.C. – (January 31, 2011) – The Biotechnology Industry Organization (BIO) announced today that former British Prime Minister Tony Blair will participate in a keynote presentation at the 2011 BIO International Convention.  BIO President and CEO Jim Greenwood will host an “Interview with Tony Blair” during Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , ,

Effective Tax Rates for Biotech

The New York Times published a misleading article and companion blog post on corporate tax rates last Thursday, leaving us scratching our heads over the claim that the biotech sector pays a paltry “effective” corporate tax rate of 4.46%, the lowest rate amongst the 20 industries surveyed.  After careful reading of the article and examination of supporting documents, we found that the authors vastly underestimated the industry’s effective tax rate. First, the authors incorrectly average Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , ,

BIO Supports Patent Reform Act of 2011: Press Release

BIO Supports Patent Reform Act of 2011 Bipartisan, consensus-oriented approach will strengthen nation’s patent system   Washington, D.C. (January 28, 2011) – Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood released the following comment on the introduction of the Patent Reform Act of 2011 (S. 23) by Senate Judiciary Committee Chairman Patrick Leahy (D-VT) earlier this week: “BIO appreciates the dedication of Chairman Leahy, Ranking Member Charles Grassley (R-IA) and the bill’s other cosponsors for their Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

BIO Applauds USDA Decision to Deregulate Biotech Alfalfa

 The U.S. Department of Agriculture announced January 27th that it will fully deregulate a variety of biotech alfalfa (so called “Roundup Ready” or “RR” alfalfa, which is genetically engineered to tolerate the herbicide glyophosate).   This decision comes after a comprehensive environmental impact statement (EIS)conducted by USDA analyzed the potential environmental impact of RR alfalfa, and concluded that it is safe and does not represent a plant pest risk.   Jim Greenwood, president and CEO of the Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , , , ,